Determination of the human papillomavirus (HPV)-specific antibody status in oral fluids of individuals vaccinated with a quadrivalent HPV vaccine
- Conditions
- Healthy women aged 18-26MedDRA version: 9.1Level: LLTClassification code 10065136Term: Human papilloma virus exposure
- Registration Number
- EUCTR2008-008605-22-AT
- Lead Sponsor
- Medizinische Universität Wien, Univ.Klinik für Dermatologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Female, healthy participants; age 18-26; no history of genital warts, abnormal Pap smears and anogenital dysplasia; fewer than 4 lifetime sexual partners
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Previous or current HPV infection; chronic disease; immunosuppression; hematologic disease; mental disorder; pregnancy
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method